<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01229449</url>
  </required_header>
  <id_info>
    <org_study_id>NL0811</org_study_id>
    <nct_id>NCT01229449</nct_id>
  </id_info>
  <brief_title>Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study</brief_title>
  <official_title>A Double-blind, Parallel-group, Placebo-controlled, Randomised, Single Dose Study to Compare Ibuprofen + Acetaminophen; Ibuprofen + Codeine (Nurofen Plus®) and Acetaminophen + Codeine (Panadeine® Extra) in Postoperative Dental Pain.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reckitt Benckiser LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Worldwide Clinical Trials</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Premier Research Group plc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>ACM Laboratories</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aptuit Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clearcut Clinical Consulting</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Reckitt Benckiser LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to assess the efficacy and tolerability of a combination of 400 mg ibuprofen
      plus 1000 mg acetaminophen, 200 mg ibuprofen plus 500 mg, acetaminophen compared with a
      combination of 400 mg ibuprofen plus 25.6 mg codeine (Nurofen Plus®) and a combination of
      1000 mg acetaminophen plus 30 mg codeine (Panadeine® Extra) in terms of total analgesic
      effect, peak analgesic effect, onset and duration of action and the subject's overall
      assessment of the study medication.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SPRID (the sum of the pain intensity difference (PID) and the pain relief (PR) score)</measure>
    <time_frame>0-12h</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>SPID (Sum of Pain Intensity Difference)</measure>
    <time_frame>0-4h, 0-6h, 0-8h, 0-12h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SPRID</measure>
    <time_frame>0-4h, 0-6h and 0-8h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TOTPAR (Total Pain Relief)</measure>
    <time_frame>0-4h, 0-6h, 0-8h and 0-12h</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">678</enrollment>
  <condition>Post-operative Pain</condition>
  <arm_group>
    <arm_group_label>Ibuprofen/acetaminophen (lower dose)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen/acetaminophen (higher dose)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nurofen Plus®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Panadeine® Extra</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Two placebo tablets</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen/acetaminophen</intervention_name>
    <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet</description>
    <arm_group_label>Ibuprofen/acetaminophen (lower dose)</arm_group_label>
    <other_name>Formulation reference number FR005/28 for combination tablet</other_name>
    <other_name>Formulation reference number FR06/01 for placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen/acetaminophen (higher dose)</intervention_name>
    <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg</description>
    <arm_group_label>Ibuprofen/acetaminophen (higher dose)</arm_group_label>
    <other_name>Formulation reference number FR005/28</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nurofen Plus®</intervention_name>
    <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®)</description>
    <arm_group_label>Nurofen Plus®</arm_group_label>
    <other_name>Reference number LOT 25W</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Panadeine® Extra</intervention_name>
    <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra)</description>
    <arm_group_label>Panadeine® Extra</arm_group_label>
    <other_name>Reference number 114555</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Two placebo tablets</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Formulation reference number FR06/01</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Main Inclusion Criteria:

        Experiencing moderate to severe pain after extraction of impacted third molars

        Main Exclusion Criteria:

        Any ongoing painful condition other than that associated with the current third molar
        surgery that could significantly interfere with the subject's suitability Any condition
        that would render the subject unsuitable to receive an NSAID, acetaminophen or codeine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen Daniels</last_name>
    <role>Principal Investigator</role>
    <affiliation>Premier Research Group Inc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Premier Research</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2010</study_first_submitted>
  <study_first_submitted_qc>October 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2010</study_first_posted>
  <last_update_submitted>October 26, 2010</last_update_submitted>
  <last_update_submitted_qc>October 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr Phillip Berry</name_title>
    <organization>Reckitt Benckiser Inc</organization>
  </responsible_party>
  <keyword>Dental pain</keyword>
  <keyword>Ibuprofen</keyword>
  <keyword>Acetaminophen</keyword>
  <keyword>Nurofen Plus®</keyword>
  <keyword>Panadeine® Extra</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Toothache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Codeine</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>July 11, 2011</submitted>
    <returned>August 3, 2011</returned>
    <submitted>February 8, 2018</submitted>
    <returned>March 9, 2018</returned>
    <submitted>May 11, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

